Cited 0 times in Scipus Cited Count

Usefulness of 18F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases

DC Field Value Language
dc.contributor.authorYoon, SH-
dc.contributor.authorKim, KS-
dc.contributor.authorKang, SY-
dc.contributor.authorSong, HS-
dc.contributor.authorJo, KS-
dc.contributor.authorChoi, BH-
dc.contributor.authorLee, SJ-
dc.contributor.authorYoon, JK-
dc.contributor.authorAn, YS-
dc.date.accessioned2014-07-18T04:30:02Z-
dc.date.available2014-07-18T04:30:02Z-
dc.date.issued2013-
dc.identifier.issn1869-3474-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/10633-
dc.description.abstractPurpose: Bone metastasis is an important factor for the treatment and prognosis of breast cancer patients. Whole-body bone scintigraphy (WBBS) can evaluate skeletal metastases, and (18)F-FDG PET/CT seems to exhibit high specificity and accuracy in detecting bone metastases. However, there is a limitation of (18)F-FDG PET in assessing sclerotic bone metastases because some lesions may be undetectable. Recent studies showed that (18)F-fluoride PET/CT is more sensitive than WBBS in detecting bone metastases. This study aims to evaluate the usefulness of (18)F-fluoride PET/CT by comparing it with WBBS and (18)F-FDG PET/CT in breast cancer patients with osteosclerotic skeletal metastases.
Materials and methods: Nine breast cancer patients with suspected bone metastases (9 females; mean age ± SD, 55.6 ± 10.0 years) underwent (99m)Tc-MDP WBBS, (18)F-FDG PET/CT and (18)F-fluoride PET/CT. Lesion-based analysis of five regions of the skeletons (skull, vertebral column, thoracic cage, pelvic bones and long bones of extremities) and patient-based analysis were performed.
Results: (18)F-fluoride PET/CT, (18)F-FDG PET/CT and WBBS detected 49, 20 and 25 true metastases, respectively. Sensitivity, specificity, positive predictive value and negative predictive value of (18)F-fluoride PET/CT were 94.2 %, 46.3 %, 57.7 % and 91.2 %, respectively. Most true metastatic lesions on (18)F-fluoride PET/CT had osteosclerotic change (45/49, 91.8 %), and only four lesions showed osteolytic change. Most lesions on (18)F-FDG PET/CT also demonstrated osteosclerotic change (17/20, 85.0 %) with three osteolytic lesions. All true metastatic lesions detected on WBBS and (18)F-FDG PET/CT were identified on (18)F-fluoride PET/CT.
Conclusion: (18)F-fluoride PET/CT is superior to WBBS or (18)F-FDG PET/CT in detecting osteosclerotic metastatic lesions. (18)F-fluoride PET/CT might be useful in evaluating osteosclerotic metastases in breast cancer patients.
-
dc.formattext/plain-
dc.language.isoen-
dc.titleUsefulness of 18F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases-
dc.typeArticle-
dc.identifier.pmid24895505-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035203/-
dc.subject.keyword18F-fluoride-
dc.subject.keyword18F-NaF . PET/CT-
dc.subject.keywordBreast cancer-
dc.subject.keywordSkeletal metastases-
dc.contributor.affiliatedAuthor김, 구상-
dc.contributor.affiliatedAuthor강, 석윤-
dc.contributor.affiliatedAuthor이, 수진-
dc.contributor.affiliatedAuthor윤, 준기-
dc.contributor.affiliatedAuthor안, 영실-
dc.type.localJournal Papers-
dc.identifier.doi10.1007/s13139-012-0178-0-
dc.citation.titleNuclear medicine and molecular imaging-
dc.citation.volume47-
dc.citation.number1-
dc.citation.date2013-
dc.citation.startPage27-
dc.citation.endPage35-
dc.identifier.bibliographicCitationNuclear medicine and molecular imaging, 47(1). : 27-35, 2013-
dc.identifier.eissn1869-3482-
dc.relation.journalidJ018693474-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Nuclear Medicine & Molecular Imaging
Files in This Item:
24895505.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse